Cardiovascular effects of erythropoietin: an update
AVR Santhanam, LV d'Uscio, ZS Katusic - Advances in pharmacology, 2010 - Elsevier
Erythropoietin (EPO) is a therapeutic product of recombinant DNA technology and it has
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …
Cardiovascular effects of erythropoietin. An update
AVR Santhanam, LV d'Uscio… - Advances in …, 2010 - mayoclinic.elsevierpure.com
Erythropoietin (EPO) is a therapeutic product of recombinant DNA technology and it has
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …
Cardiovascular effects of erythropoietin an update.
AV Santhanam, LV d'Uscio… - Advances in Pharmacology …, 2010 - europepmc.org
Erythropoietin (EPO) is a therapeutic product of recombinant DNA technology and it has
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …
Cardiovascular effects of erythropoietin an update
AVR Santhanam, LV d'Uscio… - … in pharmacology (San …, 2010 - pubmed.ncbi.nlm.nih.gov
Erythropoietin (EPO) is a therapeutic product of recombinant DNA technology and it has
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …
[引用][C] Cardiovascular Effects of Erythropoietin
AVR Santhanam, LV d'Uscio, ZS Katusic - Cardiovascular Pharmacology …, 2010 - cir.nii.ac.jp
Cardiovascular Effects of Erythropoietin | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
[HTML][HTML] Cardiovascular Effects of Erythropoietin: An Update
AVR Santhanam, LV d'Uscio… - … in pharmacology (San …, 2010 - ncbi.nlm.nih.gov
Erythropoietin (EPO) is a therapeutic product of recombinant DNA technology and it has
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …
Cardiovascular Effects of Erythropoietin: An Update
AVR Santhanam, LV d'Uscio… - Cardiovascular …, 2010 - books.google.com
258 Santhanam et al. repair of injured endothelium and neovascularization. A novel signal
transduction pathway involving EPOR—b-common heteroreceptor is postulated to enhance …
transduction pathway involving EPOR—b-common heteroreceptor is postulated to enhance …
Cardiovascular effects of erythropoietin an update.
AV Santhanam, LV d'Uscio… - Advances in Pharmacology …, 2010 - europepmc.org
Erythropoietin (EPO) is a therapeutic product of recombinant DNA technology and it has
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …